INmune Bio Inc. Their mission is to reprogram a patient's innate immune system, unlocking its full potential to combat cancer and Alzheimer's disease. With a focus on precision therapy, INmune Bio's drug candidates, INKmune™ and INB03, are designed to target specific components of the immune system to effectively treat cancer.

Additionally, their revolutionary product, XPro1595, addresses neuroinflammation as a leading cause of Alzheimer's disease. Harnessing the power of the body's natural defenses, INmune Bio's therapies promote the innate immune response to tackle unresolved medical challenges. Through rigorous clinical trials, they are at the forefront of advancing these novel treatments.

As a forward-thinking biotech company, INmune Bio Inc. Visit their website or reach out to their team to learn more about their groundbreaking research and innovative solutions